Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,170 | 40,629 | 46,721 | 14,545 | 68,578 |
| Depreciation Amortization | 242,609 | 179,096 | 116,510 | 57,732 | 244,065 |
| Accounts receivable | -16,310 | 18,095 | -5,784 | 108,686 | 17,199 |
| Other Working Capital | -133,593 | -111,847 | -109,401 | 55,039 | -61,318 |
| Other Operating Activity | 128,944 | 52,586 | 48,149 | -87,874 | 110,477 |
| Operating Cash Flow | $241,820 | $178,559 | $96,195 | $148,128 | $379,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45,939 | -32,885 | -21,252 | -12,693 | -61,836 |
| Net Acquisitions | -146,543 | N/A | -73,828 | N/A | -251,360 |
| Purchase Sale Intangibles | -1,700 | -74,328 | -500 | N/A | -4,350 |
| Other Investing Activity | -1,700 | -74,328 | -500 | 0 | -4,350 |
| Investing Cash Flow | $-194,182 | $-107,213 | $-95,580 | $-12,693 | $-317,546 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 180,000 |
| Debt Repayment | -78,179 | -68,333 | -33,969 | -23,723 | -37,012 |
| Common Stock Issued | 853 | 834 | 681 | 676 | 321 |
| Other Financing Activity | -60,796 | -40,273 | -30,929 | -3,102 | -11,502 |
| Financing Cash Flow | $-138,122 | $-107,772 | $-64,217 | $-26,149 | $131,807 |
| Exchange Rate Effect | 102 | -76 | -366 | -593 | 1,037 |
| Beginning Cash Position | 347,121 | 347,121 | 347,121 | 347,121 | 152,822 |
| End Cash Position | 256,739 | 310,619 | 283,153 | 455,814 | 347,121 |
| Net Cash Flow | $-90,382 | $-36,502 | $-63,968 | $108,693 | $194,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | 241,820 | 178,559 | 96,195 | 148,128 | 379,001 |
| Capital Expenditure | -50,939 | -32,885 | -21,252 | -12,693 | -61,836 |
| Free Cash Flow | 190,881 | 145,674 | 74,943 | 135,435 | 317,165 |